glp-1 colorectal cancer death risk study november 2025 drugs and prevention GLP‐1 receptor agonists and the

Path 1: Continue at maintenance dose This is the most conservative approach and, for many patients, the most effective

However, it does not interact with the brains hunger centers in the same way semaglutide does

Yes, mood changes in early GLP-1 treatment are documented and usually temporary.(8) The medication affects neurological pathways that extend beyond appetite, and the early adjustment period can involve some emotional variability

That matters more than you might think

The agency has reported dosing errors, products with fraudulent labels, and adverse events associated with compounded GLP-1 medications

Energy crashes